HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England - 28/02/23
Highlights |
• | First study to evaluate the potential risk of HTLV transmission amongst people who use HIV-PrEP. |
• | No (0/2015) HTLV-1/HTLV-2 cases found in people who use HIV-PrEP in England. |
• | Similar studies are needed amongst HIV-PrEP uses elsewhere, particularly in HTLV-1 endemic settings. |
Summary |
Objectives |
HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England.
Methods |
An unlinked anonymous seroprevalence study.
Results |
Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% – 0.18%).
Conclusions |
There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.
Le texte complet de cet article est disponible en PDF.Keywords : Human T cell lymphotropic virus type 1 (HTLV-1), HIV pre-exposure prophylaxis, Gay, Bisexual and other men who have sex with men (GBMSM)
Plan
Vol 86 - N° 3
P. 245-247 - mars 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?